NIH VideoCast - NIH Director's Seminar Series: Novel measures of fetal growth and development: state of the art tools to assess fetal health

Skip Navigation

NIH Director's Seminar Series: Novel measures of fetal growth and development: state of the art tools to assess fetal health

Loading... Loading video...

123 Views

Air date:	Friday, January 19, 2024, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 123 (95 Live, 28 On-demand)
Category:	NIH Director's Seminars
Runtime:	01:01:02
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Healthy fetal growth is essential for newborn well-being, pediatric development, and subsequent adult health consistent with the developmental origins of health and disease hypothesis. Both fetal undergrowth and overgrowth portend adverse outcomes and require clinical intervention. Fetal growth is often assessed by ultrasonographic measurement of two-dimensional (2D) fetal biometrics to calculate an estimated fetal weight (EFW) that is then compared against a standard. However, EFW is a poor measure of actual growth. Recently, more sophisticated measures have been developed including three-dimensional (3D) ultrasound that permit the analysis of volume pixels (voxels) for specific anatomic regions of a developing fetus. Such analytic tools now allow the examiner to quantify fetal soft tissue and organ volume parameters in ways not possible using conventional 2D ultrasound. Dr. Grantz will discuss developing standards for fetal size and growth velocity and show how new measures of fetal growth identify fetuses at risk for abnormal growth, adverse outcomes, and poorer health in postnatal life.

NLM Title:	Novel measures of fetal growth and development : state of the art tools to assess fetal health / Katherine Grantz.
Author:	Grantz, Katherine. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): Healthy fetal growth is essential for newborn well-being, pediatric development, and subsequent adult health consistent with the developmental origins of health and disease hypothesis. Both fetal undergrowth and overgrowth portend adverse outcomes and require clinical intervention. Fetal growth is often assessed by ultrasonographic measurement of two-dimensional (2D) fetal biometrics to calculate an estimated fetal weight (EFW) that is then compared against a standard. However, EFW is a poor measure of actual growth. Recently, more sophisticated measures have been developed including three-dimensional (3D) ultrasound that permit the analysis of volume pixels (voxels) for specific anatomic regions of a developing fetus. Such analytic tools now allow the examiner to quantify fetal soft tissue and organ volume parameters in ways not possible using conventional 2D ultrasound. Dr. Grantz will discuss developing standards for fetal size and growth velocity and show how new measures of fetal growth identify fetuses at risk for abnormal growth, adverse outcomes, and poorer health in postnatal life.
Subjects:	Fetal Development--physiology Fetal Growth Retardation Fetal Monitoring--methods Fetus--abnormalities Pregnancy Outcome
Publication Types:	Lecture Webcast
NLM Classification:	WQ 210.5
NLM ID:	9918768586206676
CIT Live ID:	54137
Permanent link:	https://videocast.nih.gov/watch=54137

Related Videos...